Combined extract of heated 4T1 and a heatkilled preparation of lactobacillus Casei in a mouse model of breast cancer

Iranian Journal of Medical Sciences

Volumn 42, Issue 5, 2017, Pages 457-464

  Jafari, Sajjad ^a   Froushani, Seyyed Meysam Abtahi ^a   Tokmachi, Amir ^a  

^a URMIA UNIVERSITY   (Iran)

Author keywords

4T1 cell line; Breast neoplasms; Immunotherapy; Lactobacillus casei

Indexed keywords

4T1 CELL EXTRACT; CELL EXTRACT; GAMMA INTERFERON; INTERLEUKIN 4; LACTATE DEHYDROGENASE; NITRIC OXIDE; PHOSPHATE BUFFERED SALINE; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; FREEZE THAWING; IMMUNE RESPONSE; LACTOBACILLUS CASEI; MOUSE; MOUSE MODEL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; SPLEEN CELL; TREATMENT DURATION;

EID: 85028599774     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rohan TE, Xue X, Lin HM, D’Alfonso TM, Ginter PS, Oktay MH, et al. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. J Natl Cancer Inst. 2014;106. doi: 10.1093/jnci/dju136.
2. Raval RR, Sharabi AB, Walker AJ, Drake CG, Sharma P. Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer. J Immunother Cancer. 2014;2:14. doi: 10.1186/2051-1426-2-14.
3. Corthay A. Does the immune system naturally protect against cancer? Front Immunol. 2014;5:197. doi: 10.3389/ fimmu.2014.00197.
4. Maueroder C, Munoz LE, Chaurio RA, Herrmann M, Schett G, Berens C. Tumor immunotherapy: lessons from autoimmunity. Front Immunol. 2014;5:212. doi: 10.3389/fimmu.2014.00212.
5. Wood LM, Paterson Y. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. Front Cell Infect Microbiol. 2014;4:51. doi: 10.3389/fcimb.2014.00051.
6. Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol. 2009;30:23-32. doi: 10.1016/j.it.2008.09.006.
7. Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev Sci Tech. 2007;26:29-48.
8. De Gregorio E, Tritto E, Rappuoli R. Alum adjuvanticity: unraveling a century old mystery. Eur J Immunol. 2008;38:2068-71. doi: 10.1002/eji.200838648.
9. Claassen E, de Leeuw W, de Greeve P, Hendriksen C, Boersma W. Freund’s complete adjuvant: an effective but disagreeable formula. Res Immunol. 1992;143:478-83; discussion 572
10. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008;8:228. doi: 10.1186/1471-2407-8-228.
11. Hori T, Kiyoshima J, Yasui H. Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice. Biosci Biotechnol Biochem. 2003;67:420-2. doi: 10.1271/bbb.67.420.
12. Rizzello V, Bonaccorsi I, Dongarra ML, Fink LN, Ferlazzo G. Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. J Biomed Biotechnol. 2011;2011:473097. doi: 10.1155/2011/473097.
13. Dwivedi A, Nomikou N, Nigam PS, McHale AP. The effects of microencapsulated Lactobacillus casei on tumour cell growth: In vitro and in vivo studies. Int J Med Microbiol. 2012;302:293-9. doi: 10.1016/j.ijmm.2012.09.002.
14. Soltan Dallal MM, Yazdi MH, Holakuyee M, Hassan ZM, Abolhassani M, Mahdavi M. Lactobacillus casei ssp.casei induced Th1 cytokine profile and natural killer cells activity in invasive ductal carcinoma bearing mice. Iran J Allergy Asthma Immunol. 2012;11:183-9. doi: 011.02/ijaai.183189.
15. Bloksma N, de Heer E, van Dijk H, Willers JM. Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria. Clin Exp Immunol. 1979;37:367-75.
16. Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest. 2014;43:54-68. doi: 10.3109/08820139.2013.825269.
17. Ramakrishnan S, Laxminarayan S, Wesensten NJ, Kamimori GH, Balkin TJ, Reifman J. Dose-dependent model of caffeine effects on human vigilance during total sleep deprivation. J Theor Biol. 2014;358:11-24. doi: 10.1016/j.jtbi.2014.05.017.
18. Shilling DA, Smith MJ, Tyther R, Sheehan D, England K, Kavanagh EG, et al. Salmonella typhimurium stimulation combined with tumour-derived heat shock proteins induces potent dendritic cell anti-tumour responses in a murine model. Clin Exp Immunol. 2007;149:109-16. doi: 10.1111/j.1365-2249.2007.03393.x.
19. Morecki S, Yacovlev E, Gelfand Y, Trembovler V, Shohami E, Slavin S. Induction of antitumor immunity by indomethacin. Cancer Immunol Immunother. 2000;48:613-20.
20. Mahmood K, Jadoon S, Mahmood Q, Irshad M, Hussain J. Synergistic effects of toxic elements on heat shock proteins. Biomed Res Int. 2014;2014:564136. doi: 10.1155/2014/564136.
21. Ahmed K, Zaidi SF. Treating cancer with heat: hyperthermia as promising strategy to enhance apoptosis. J Pak Med Assoc. 2013;63:504-8.
22. Ciocca DR, Cayado-Gutierrez N, Maccioni M, Cuello-Carrion FD. Heat shock proteins (HSPs) based anti-cancer vaccines. Curr Mol Med. 2012;12:1183-97.
23. Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: role in antigen presentation and immune stimulation. Int J Hyperthermia. 2002;18:563-75. doi: 10.1080/02656730210166140.
24. Bausero MA, Page DT, Osinaga E, Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol. 2004;25:243-51. doi: 10.1159/000081387.
25. Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J. 2011;52:379-92. doi: 10.3349/ymj.2011.52.3.429.
26. Tolle LB, Standiford TJ. Danger-associated molecular patterns (DAMPs) in acute lung injury. J Pathol. 2013;229:145-56. doi: 10.1002/path.4124.
27. Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35 Suppl: S185-98. doi: 10.1016/j.semcancer.2015.03.004.
28. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002;168:171-8.
29. Nagai S, Toi M. Interleukin-4 and breast cancer. Breast Cancer. 2000;7:181-6.
30. Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 2004;18:1255-7. doi: 10.1096/fj.03-1098fje.
31. Wobke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol. 2014;5:244. doi: 10.3389/fphys.2014.00244.
32. Heppner GH, Miller FR, Shekhar PM. Nontransgenic models of breast cancer. Breast Cancer Res. 2000;2:331-4.
33. Pahl J, Cerwenka A. Tricking the balance: NK cells in anti-cancer immunity. Immunobiology. 2017;222:11-20. doi: 10.1016/j.imbio.2015.07.012.
34. Josephs DH, Bax HJ, Karagiannis SN. Tumour-associated macrophage polarisation and re-education with immunotherapy. Front Biosci (Elite Ed). 2015;7:293-308.
35. Nanno M, Shimizu-Takeda T, Mike A, Ohwaki M, Togashi Y, Suzuki R, et al. Increased production of cytotoxic macrophage progenitors by Lactobacillus casei in mice. J Leukoc Biol. 1989;46:89-95.